Titre : Carcinome bronchogénique

Carcinome bronchogénique : Questions médicales fréquentes

Termes MeSH sélectionnés :

Prospective Studies
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Carcinome bronchogénique : Questions médicales les plus fréquentes", "headline": "Carcinome bronchogénique : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Carcinome bronchogénique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-01", "dateModified": "2025-12-21", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Carcinome bronchogénique" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Tumeurs des bronches", "url": "https://questionsmedicales.fr/mesh/D001984", "about": { "@type": "MedicalCondition", "name": "Tumeurs des bronches", "code": { "@type": "MedicalCode", "code": "D001984", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C08.785.520.100" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Carcinome pulmonaire non à petites cellules", "alternateName": "Carcinoma, Non-Small-Cell Lung", "url": "https://questionsmedicales.fr/mesh/D002289", "about": { "@type": "MedicalCondition", "name": "Carcinome pulmonaire non à petites cellules", "code": { "@type": "MedicalCode", "code": "D002289", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C08.785.520.100.220.500" } } }, { "@type": "MedicalWebPage", "name": "Carcinome pulmonaire à petites cellules", "alternateName": "Small Cell Lung Carcinoma", "url": "https://questionsmedicales.fr/mesh/D055752", "about": { "@type": "MedicalCondition", "name": "Carcinome pulmonaire à petites cellules", "code": { "@type": "MedicalCode", "code": "D055752", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C08.785.520.100.220.750" } } } ], "about": { "@type": "MedicalCondition", "name": "Carcinome bronchogénique", "alternateName": "Carcinoma, Bronchogenic", "code": { "@type": "MedicalCode", "code": "D002283", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Ravikanth Reddy", "url": "https://questionsmedicales.fr/author/Ravikanth%20Reddy", "affiliation": { "@type": "Organization", "name": "Department of Radiology, St. John's Hospital, Bengaluru 560034, Karnataka, India. ravikanthreddy06@gmail.com." } }, { "@type": "Person", "name": "Chika Miyasaka", "url": "https://questionsmedicales.fr/author/Chika%20Miyasaka", "affiliation": { "@type": "Organization", "name": "The Department of Pathology, Kansai Medical University." } }, { "@type": "Person", "name": "Koji Tsuta", "url": "https://questionsmedicales.fr/author/Koji%20Tsuta", "affiliation": { "@type": "Organization", "name": "The Department of Pathology, Kansai Medical University." } }, { "@type": "Person", "name": "Paul Zarogoulidis", "url": "https://questionsmedicales.fr/author/Paul%20Zarogoulidis", "affiliation": { "@type": "Organization", "name": "3rd University General Hospital, ''AHEPA'' University Hospital, Thessaloniki, Greece." } }, { "@type": "Person", "name": "Kosmas Tsakiridis", "url": "https://questionsmedicales.fr/author/Kosmas%20Tsakiridis", "affiliation": { "@type": "Organization", "name": "Thoracic Surgery Department, ''Interbalkan'' European Medical Center, Thessaloniki, Greece." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Frequency and risk factors of atrial fibrillation after acute abdominal surgery: A prospective cohort study.", "datePublished": "2023-11-17", "url": "https://questionsmedicales.fr/article/37975533", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/aas.14360" } }, { "@type": "ScholarlyArticle", "name": "Integrin β Expression as a New Diagnostic Marker for Arteriovenous Thrombosis: A Single-Center Prospective Study.", "datePublished": "2023-11-15", "url": "https://questionsmedicales.fr/article/37998519", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/jcdd10110461" } }, { "@type": "ScholarlyArticle", "name": "Coeliac disease: what can we learn from prospective studies about disease risk?", "datePublished": "2023-11-14", "url": "https://questionsmedicales.fr/article/37972632", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/S2352-4642(23)00232-8" } }, { "@type": "ScholarlyArticle", "name": "Comparing Epley Maneuver, Betahistine, and Dimenhydrinate in the Treatment of Benign Paroxysmal Positional Vertigo: A Prospective Study.", "datePublished": "2023-11-13", "url": "https://questionsmedicales.fr/article/38440440", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s12070-023-04282-3" } }, { "@type": "ScholarlyArticle", "name": "Polidocanol sclerotherapy for the treatment of aneurysmal bone cyst, with or without pathological fractures: A prospective, comparative study.", "datePublished": "2023-11-03", "url": "https://questionsmedicales.fr/article/38009081", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jor.2023.10.022" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies de l'appareil respiratoire", "item": "https://questionsmedicales.fr/mesh/D012140" }, { "@type": "ListItem", "position": 3, "name": "Tumeurs de l'appareil respiratoire", "item": "https://questionsmedicales.fr/mesh/D012142" }, { "@type": "ListItem", "position": 4, "name": "Tumeurs du poumon", "item": "https://questionsmedicales.fr/mesh/D008175" }, { "@type": "ListItem", "position": 5, "name": "Tumeurs des bronches", "item": "https://questionsmedicales.fr/mesh/D001984" }, { "@type": "ListItem", "position": 6, "name": "Carcinome bronchogénique", "item": "https://questionsmedicales.fr/mesh/D002283" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Carcinome bronchogénique - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Carcinome bronchogénique", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2026-02-06", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Carcinome bronchogénique", "description": "Comment diagnostiquer un carcinome bronchogénique ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels marqueurs tumoraux sont associés ?\nQuelle est l'importance de l'imagerie ?\nQuand faire un scanner thoracique ?", "url": "https://questionsmedicales.fr/mesh/D002283?mesh_terms=Prospective+Studies&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Carcinome bronchogénique", "description": "Quels sont les symptômes courants ?\nComment la douleur thoracique se manifeste-t-elle ?\nY a-t-il des symptômes systémiques ?\nQuand consulter un médecin pour des symptômes ?\nLes symptômes varient-ils selon le type de carcinome ?", "url": "https://questionsmedicales.fr/mesh/D002283?mesh_terms=Prospective+Studies&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Carcinome bronchogénique", "description": "Comment prévenir le carcinome bronchogénique ?\nLe dépistage est-il utile ?\nQuels sont les conseils pour arrêter de fumer ?\nL'alimentation joue-t-elle un rôle ?\nLes expositions professionnelles sont-elles un risque ?", "url": "https://questionsmedicales.fr/mesh/D002283?mesh_terms=Prospective+Studies&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Carcinome bronchogénique", "description": "Quels traitements sont disponibles ?\nQuand la chirurgie est-elle recommandée ?\nQuels sont les effets secondaires de la chimiothérapie ?\nQu'est-ce que la radiothérapie palliative ?\nLes thérapies ciblées sont-elles efficaces ?", "url": "https://questionsmedicales.fr/mesh/D002283?mesh_terms=Prospective+Studies&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Carcinome bronchogénique", "description": "Quelles complications peuvent survenir ?\nComment les métastases affectent-elles le corps ?\nQu'est-ce qu'une obstruction bronchique ?\nLes infections pulmonaires sont-elles fréquentes ?\nComment gérer les complications ?", "url": "https://questionsmedicales.fr/mesh/D002283?mesh_terms=Prospective+Studies&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Carcinome bronchogénique", "description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque ?\nLes antécédents familiaux jouent-ils un rôle ?\nLes maladies pulmonaires chroniques sont-elles un facteur ?\nL'exposition à des produits chimiques est-elle risquée ?", "url": "https://questionsmedicales.fr/mesh/D002283?mesh_terms=Prospective+Studies&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer un carcinome bronchogénique ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par imagerie (radiographie, scanner) et biopsie." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent la radiographie thoracique, la tomodensitométrie et la bronchoscopie." } }, { "@type": "Question", "name": "Quels marqueurs tumoraux sont associés ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les marqueurs comme le CEA et le CYFRA 21-1 peuvent être utilisés pour le suivi." } }, { "@type": "Question", "name": "Quelle est l'importance de l'imagerie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'imagerie permet de visualiser les tumeurs et d'évaluer leur taille et leur localisation." } }, { "@type": "Question", "name": "Quand faire un scanner thoracique ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Un scanner est recommandé si des symptômes respiratoires persistent ou s'aggravent." } }, { "@type": "Question", "name": "Quels sont les symptômes courants ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent toux persistante, essoufflement, douleur thoracique et hémoptysie." } }, { "@type": "Question", "name": "Comment la douleur thoracique se manifeste-t-elle ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "La douleur thoracique peut être aiguë ou sourde, souvent aggravée par la respiration." } }, { "@type": "Question", "name": "Y a-t-il des symptômes systémiques ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, fatigue, perte de poids et fièvre peuvent également être présents." } }, { "@type": "Question", "name": "Quand consulter un médecin pour des symptômes ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Consultez si vous avez une toux persistante ou des difficultés respiratoires." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type de carcinome ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier selon le type histologique du carcinome bronchogénique." } }, { "@type": "Question", "name": "Comment prévenir le carcinome bronchogénique ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éviter le tabagisme et l'exposition à des agents cancérigènes réduit le risque." } }, { "@type": "Question", "name": "Le dépistage est-il utile ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le dépistage par scanner est recommandé pour les fumeurs à risque élevé." } }, { "@type": "Question", "name": "Quels sont les conseils pour arrêter de fumer ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Consultez un professionnel, utilisez des substituts nicotiniques et rejoignez des groupes de soutien." } }, { "@type": "Question", "name": "L'alimentation joue-t-elle un rôle ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en fruits et légumes peut réduire le risque de cancer du poumon." } }, { "@type": "Question", "name": "Les expositions professionnelles sont-elles un risque ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à l'amiante et à d'autres substances toxiques augmente le risque." } }, { "@type": "Question", "name": "Quels traitements sont disponibles ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent chirurgie, chimiothérapie, radiothérapie et thérapies ciblées." } }, { "@type": "Question", "name": "Quand la chirurgie est-elle recommandée ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La chirurgie est recommandée pour les tumeurs localisées et opérables." } }, { "@type": "Question", "name": "Quels sont les effets secondaires de la chimiothérapie ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires incluent nausées, fatigue, perte de cheveux et infections." } }, { "@type": "Question", "name": "Qu'est-ce que la radiothérapie palliative ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "La radiothérapie palliative soulage la douleur et d'autres symptômes sans guérir le cancer." } }, { "@type": "Question", "name": "Les thérapies ciblées sont-elles efficaces ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont efficaces pour certains types de carcinome bronchogénique avec mutations spécifiques." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent métastases, pneumonie et obstruction des voies respiratoires." } }, { "@type": "Question", "name": "Comment les métastases affectent-elles le corps ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Les métastases peuvent toucher d'autres organes, entraînant des symptômes variés selon la localisation." } }, { "@type": "Question", "name": "Qu'est-ce qu'une obstruction bronchique ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "L'obstruction bronchique se produit lorsque la tumeur bloque les voies respiratoires, causant des difficultés respiratoires." } }, { "@type": "Question", "name": "Les infections pulmonaires sont-elles fréquentes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les infections pulmonaires comme la pneumonie sont fréquentes chez les patients atteints." } }, { "@type": "Question", "name": "Comment gérer les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "La gestion des complications nécessite un suivi médical régulier et des traitements adaptés." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Le tabagisme, l'exposition à l'amiante et la pollution de l'air sont des facteurs de risque majeurs." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque augmente avec l'âge, surtout après 55 ans." } }, { "@type": "Question", "name": "Les antécédents familiaux jouent-ils un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de cancer du poumon augmentent le risque." } }, { "@type": "Question", "name": "Les maladies pulmonaires chroniques sont-elles un facteur ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme la BPCO augmentent le risque de développer un carcinome bronchogénique." } }, { "@type": "Question", "name": "L'exposition à des produits chimiques est-elle risquée ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des produits chimiques comme le benzène et le formaldéhyde est un risque." } } ] } ] }

Sources (10000 au total)

Frequency and risk factors of atrial fibrillation after acute abdominal surgery: A prospective cohort study.

Scarce data exist on the true incidence of postoperative atrial fibrillation (POAF) after acute abdominal surgery and associated outcomes. The current study aimed to identify the frequencies of clinic... This study was a prospective, single-center cohort study of unselected adult patients referred for acute abdominal surgery during a 3-month period. Through careful review, demographics, comorbidity, a... In total, 450 patients were enrolled. Clinically recognized in-hospital POAF was observed in 22 patients (4.9%). All cases were observed in patients aged ≥60 years, corresponding to 22 of 164 patients... In conclusion, this prospective study of POAF in patients undergoing acute abdominal surgery showed that one in 20 patients developed clinically recognized in-hospital POAF. Multiple risk factors of P...

Polidocanol sclerotherapy for the treatment of aneurysmal bone cyst, with or without pathological fractures: A prospective, comparative study.

Polidocanol sclerotherapy in the treatment of aneurysmal bone cysts (ABCs) with or without pathological fractures has been a topic of debate. While some studies recommend intralesional curettage as th... This study evaluates the use of polidocanol-based percutaneous sclerosant therapy in 28 patients with ABCs, of which 8 patients had pathological fracture. The patients received injections every four w... In group A (without pathological fractures), 14 out of 17 (82.4 %) lesions healed without any significant residual lesion. Three out of 17 (17.6 %) patients required further surgical intervention and ... The study concludes that polidocanol sclerotherapy is an effective treatment option for patients with ABCs, with or without pathological fractures, and has the potential to become the new treatment of...

Prospective Multicenter Study of Salto Talaris Ankle Arthroplasty With Minimum 4-Year Follow-Up.

Total ankle arthroplasty (TAA) continues to be investigated as a primary treatment for end-stage ankle arthritis. The objective of this study is to report mid- to long-term results of the Salto Talari... This was a retrospective study of prospectively collected data from 2 multicenter cohort studies from 3 centers. Three hundred fourteen subjects who received a Salto Talaris TAA from 2005 to 2015 were... Significant improvements were seen in pain and physical function scores at 2-year follow-up and were generally maintained through most recent follow-up. The survival rate of the prosthesis was >95% (n... Treatment of end-stage ankle arthritis with this implant provided patients with improved pain and functional outcome scores at mid- to long-term follow-up. The significant improvements reported at 2-4... Level III, retrospective cohort study....

Adherence to Sulfur Microbial Diet and Ovarian Cancer Survival: Evidence from a Prospective Cohort Study.

The study aims to investigate the role of the sulfur microbial diet in the survival of ovarian cancer (OC).... A prospective cohort study is conducted with 703 patients diagnosed with OC between 2015 and 2020. Diet information is collected using a validated food frequency questionnaire. Deaths are ascertained ... Adherence to the sulfur microbial diet, characterized by high intakes of red meats and processed meats, and low intakes of fruits, vegetables, and whole grains, is associated with poor survival in OC ...

Prospective, Randomized Study of Fibrinogen Concentrate Versus Cryoprecipitate for Correcting Hypofibrinogenemia in Cardiac Surgery Patients.

Cardiac surgery with cardiopulmonary bypass (CPB) is associated with hypofibrinogenemia and severe bleeding requiring transfusion. Guidelines recommend cryoprecipitate or fibrinogen concentrate (FC) f... A single-center, prospective, randomized study evaluating patients with hypofibrinogenemia after cardiac surgery. The primary endpoint was direct treatment cost. Secondary endpoints included the chang... A single-center study in Astana, Kazakhstan.... Participants who underwent CPB from 2021 to 2022 and developed clinically significant bleeding and hypofibrinogenemia.... Patients were randomized to receive cryoprecipitate or FC.... Eighty-eight adult patients with acquired hypofibrinogenemia (<2.0 g/L) after CPB were randomized to receive cryoprecipitate (N = 40) or FC (N = 48), with similar demographics between groups. Overall,... Analysis of plasma fibrinogen concentration showed that cryoprecipitate and FC had comparable effectiveness. However, FC is advantageous over cryoprecipitate due to its ease of handling, lower cost, a...

Prevalence of metabolic syndrome and chronic inflammation in psoriasis before and after biologic therapy: a prospective study.

As a chronic inflammatory disease, psoriasis affects not only the skin but also the metabolic profile of the patients. Biologic therapies, including tumor necrosis alpha (TNF-a) inhibitors and interle... We performed a longitudinal case-control study on 106 psoriasis patients and an equal number of controls without the disease, as well as a prospective study on the patient group with the end point bei... At baseline, the number of psoriasis patients suffering from obesity, metabolic syndrome, and chronic inflammation significantly outnumbered controls (p<0.05), with the calculated odds ratio being 1.8... According to our results, biologic therapies improve the overall metabolic and inflammatory profiles of psoriasis patients, the most significant ameliorations being noticed for serum HDL, CRP, and ESR...